Seegene and Springer Nature Announce Strategic Alliance

- Strategic alliance aims to foster collaboration with researchers working in various disease fields by using best-in-class PCR diagnostic technology - Companies will facilitate C-level cooperatio...

Seegene and UK Health Security Agency convene a summit to collectively realize “a World Free from All Diseases”

- Two CEOs met at Seegene headquarters to discuss and concurred with Seegene's vision - Seegene’s swift responses to the COVID-19 pandemic and digital solutions through AI implementation were prese...

Seegene Announces Collaboration with Microsoft to Realize ‘a World Free from All Diseases’

- Strategic collaboration to open a new chapter in the field of molecular diagnostics that aspires to 'a world free from all diseases and future pandemics' - Digitally enhance Seegene's automated d...

Seegene Reinforces Commitment to Strong ESG Management with 100% Recyclable, Styrofoam-Free Shipping Boxes

- 100% recyclable package made with eco-friendly and FSC-certified materials to proactively meet evolving global environmental regulations - Patent design provides a 30% increase in load capacity ...

Seegene Unveils ‘Open Innovation Program Powered by Seegene’ in Partnership with Springer Nature

- The program is a part of the Seegene OneSystemTM business aimed at creating a ‘world free from all diseases' - Collaborating with clinical researchers worldwide, Seegene will share its technolo...

Springer Nature to Join Seegene’s OneSystem™ Business as Strategic Partner

- Seegene announces strategic partnership with Springer Nature to expand OneSystem™ Business - Seegene and Springer Nature to jointly launch global assay development project - Springer Nature exp...

Seegene and Werfen Partner to Collaborate on OneSystem™ Business to Develop Syndromic qPCR Assays

Seegene Inc. (KQ096530), a leading South Korean company which provides a total solution for PCR molecular diagnostics, announced an agreement with Werfen, a worldwide leader in Specialized Diagnosti...

Seegene Obtains IVDR Certification for 30 Diagnostic Assays

• Seegene certifies diagnostic assays for digestive, respiratory, women's diseases, and human papillomavirus to meet IVDR requirements • New regulation sets improved standards to ensure higher leve...

IVI and Seegene's Partnership to Tackle HPV in Developing Countries through Advanced Diagnostic Technology

Seegene and the International Vaccine Institute (IVI), an international organization specializing in vaccines under the World Health Organization (WHO), have signed a memorandum of understanding (MOU)...

Seegene Wins Tender for Diagnostic Reagents Worth 45 Million Euros in Italy

Seegene to supply diagnostic reagents to public hospitals in Tuscany for five yearsBidding scale increased by six-fold with non-COVID products accounting for 43% due to the clinical utility of molec...

Seegene launches world’s first In-life PCR campaign in Vietnam

Seegene to pave way for PCR testing at local clinics with EU-approved multiplex test and fully automated PCR solution

Seoul (June 29, 2022) Seegene Inc. (KQ096530), South Korea’s leading molecular diagnostics (MDx) company, has obtained EU approval for its Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay that is compatible ...

Seegene develops PCR test to detect monkeypox virus

Assay targets monkeypox virus and can deliver results in 90 minutesCompany swiftly rolls out product using its automated assay development system“Seegene will strive to make accurate tests for emer...

Seegene unveils ‘$12 PCR testing’ initiative to help end COVID-19 pandemic

Includes asymptomatic testing at community-based facilities to prevent widespread transmissions Regular testing for COVID-19, flu, RSV crucial for staying safe as anti-virus restrictions are eased ...